<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">akusherstvo</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics, Gynecology and Reproduction</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство, Гинекология и Репродукция</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7347</issn><issn pub-type="epub">2500-3194</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2313-7347.2019.13.4.289-296</article-id><article-id custom-type="elpub" pub-id-type="custom">akusherstvo-597</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLE</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ</subject></subj-group></article-categories><title-group><article-title>Clinical and histological features of purely stromal cell ovarian tumors</article-title><trans-title-group xml:lang="ru"><trans-title>Клинико-гистологические особенности чисто стромально-клеточных опухолей яичников</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4915-2219</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бейшембаев</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Beishembaev</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бейшембаев Алмаз Мукашевич – к.м.н., зав. кафедрой онкологии, гематологии, лучевой диагностики и терапии факультета усовершенствования врачей</p><p>Кыргызская Республика, 720064 Бишкек, ул. Боконбаева, д. 144а.</p></bio><bio xml:lang="en"><p>Almaz М. Beishembaev – PhD, Head of the Department of Oncology, Hematology, Radiation Diagnostics and Therapy, Faculty of Advanced Medical Education</p><p>144а Bokonbaev St., Bishkek 720064, Kyrgyz Republic.</p></bio><email xlink:type="simple">almazyaka@yandex.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1270-9917</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жорданиа</surname><given-names>К. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhordania</surname><given-names>K. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Жорданиа Кирилл Иосифович – д.м.н., профессор, онкогинеколог, ведущий научный сотрудник отделения гинекологии</p><p>Россия, 115478 Москва, Каширское шоссе, д. 24.</p></bio><bio xml:lang="en"><p>Kirill I. Zhordania – MD, PhD, Gynecologist-Oncologist, Leading Researcher, Department of Gynecology</p><p>24 Kashirskoe Av., Moscow 115478, Russia.</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Кыргызский государственный медицинский институт переподготовки и повышения квалификации имени С.Б. Даниярова Министерства здравоохранения Кыргызской Республики</institution></aff><aff xml:lang="en"><institution>Kyrgyz State Medical Institute of Advanced Training and Retraining named after S.B. Daniyarov, Health Ministry of Kyrgyz Republic</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр онкологии имени Н.Н. Блохина» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.N. Blokhin National Medical Research Center of Oncology,&#13;
Health Ministry of Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>15</day><month>01</month><year>2020</year></pub-date><volume>13</volume><issue>4</issue><fpage>289</fpage><lpage>296</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Beishembaev A.M., Zhordania K.I., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Бейшембаев А.М., Жорданиа К.И.</copyright-holder><copyright-holder xml:lang="en">Beishembaev A.M., Zhordania K.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gynecology.su/jour/article/view/597">https://www.gynecology.su/jour/article/view/597</self-uri><abstract><sec><title>Aim</title><p>Aim: to identify clinical and histologic features of pure stromal ovarian tumors.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. We analyzed the clinical data from patients treated and followed up at the Blokhin National Medical Research Center of Oncology and the National Center of Oncology and Hematology of the Kyrgyz Republic.</p></sec><sec><title>Results</title><p>Results. Data on necrobiotic changes, malignancy, stages of the disease and the survival of 14 patients with pure stromal ovarian tumors have been obtained.</p></sec><sec><title>Conclusion</title><p>Conclusion. The main factors of unfavorable prognosis in patients with ovarian tecoma are tumor necrosis, degree of malignancy and mitotic activity.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Цель исследования</title><p>Цель исследования: выявить клинико-гистологические особенности чисто стромально-клеточных опухолей яичников.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Клинический материал получен у пациенток, получавших лечение и находившихся под наблюдением в ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» МЗ РФ и Национальном центре онкологии и гематологии Министерства здравоохранения Кыргызской Республики.</p></sec><sec><title>Результаты</title><p>Результаты. Были получены данные по частоте некробиотических изменений, злокачественности, стадий заболевания и их влияние на выживаемость среди 14 пациенток с чисто стромально-клеточными опухолями яичников.</p></sec><sec><title>Заключение</title><p>Заключение. Основными факторами неблагоприятного прогноза у пациенток с текомой яичников являются наличие некроза в опухоли, степень злокачественности и определение митотической активности.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>стромально-клеточные опухоли яичников</kwd><kwd>текома яичников</kwd><kwd>фибросаркома</kwd><kwd>рак яичников</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ovarian stromal tumors</kwd><kwd>ovarian tecoma</kwd><kwd>fibrosarcoma</kwd><kwd>ovarian cancer</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Швачко С.А., Грицай А.Н., Лазарева Н.И. и др. Саркомы яичников: обзор литературы. Опухоли женской репродуктивной системы. 2010;(3):88–94. DOI: 10.17650/1994-4098-2010-0-3-88-94.</mixed-citation><mixed-citation xml:lang="en">Shvachko S.A., Gritsay A.N., Lazareva N.I. et al. Ovarian sarcomas: literature review. [Sarkomy yaichnikov: obzor literatury]. Opuholi zhenskoj reproduktivnoj sistemy. 2010;(3):88–94. (In Russ.). DOI: 10.17650/1994-4098-2010-0-3-88-94.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2018 году. М.: МНИОИ им. П.А. Герцена – филиал НМИРЦ МЗ РФ, 2019. 236 с. Режим доступа: http://www.oncology.ru/service/statistics/condition/2018.pdf.</mixed-citation><mixed-citation xml:lang="en">Kaprin A.D., Starinskiy V.V., Petrova G.V. The status of cancer care for the population of Russia in 2018. [Sostoyanie onkologicheskoj pomoshchi naseleniyu Rossii v 2018 godu]. Moskva: MNIOI im. P.A. Gercena – filial NMIRC MZ RF, 2019. 231 s. (In Russ.). Available at: http://www.oncology.ru/service/statistics/condition/2018.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Бейшембаев А.М. Клинико-морфологические особенности гранулезоклеточных опухолей яичников взрослого типа. Здравоохранение Кыргызстана. 2018;(3):22–5.</mixed-citation><mixed-citation xml:lang="en">Beishembaev A.M. Clinical and morphological features of adult granulosa cell tumors of the ovaries. [Kliniko-morfologicheskie osobennosti granulezokletochnyh opuholej yaichnikov vzroslogo tipa]. Zdravoohranenie Kyrgyzstana. 2018;(3):22–5. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ting Y., Yang L.I., Juan Z. et al. Ovarian thecoma with massive pleural effusion in postmenopausal women: A case report. Mol Clin Oncol. 2016;4(6):1003–5. DOI: 10.3892/mco.2016.853.</mixed-citation><mixed-citation xml:lang="en">Ting Y., Yang L.I., Juan Z. et al. Ovarian thecoma with massive pleural effusion in postmenopausal women: A case report. Mol Clin Oncol. 2016;4(6):1003–5. DOI: 10.3892/mco.2016.853.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Burandt E., Young R.H. Thecoma of the ovary: a report of 70 cases emphasizing aspects of its histopathology different from those often portrayed and its differential diagnosis. Am J Surg Pathol. 2014;38(8):1023–32. DOI: 10.1097/PAS.0000000000000252.</mixed-citation><mixed-citation xml:lang="en">Burandt E., Young R.H. Thecoma of the ovary: a report of 70 cases emphasizing aspects of its histopathology different from those often portrayed and its differential diagnosis. Am J Surg Pathol. 2014;38(8):1023–32. DOI: 10.1097/PAS.0000000000000252.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cha M.Y., Roh H.J., You S.K. et al. Meigs’ syndrome with elevated serum CA-125 level in a case of ovarian fibrothecoma. Eur J Gynaecol Oncol. 2014;35(6):734–7.</mixed-citation><mixed-citation xml:lang="en">Cha M.Y., Roh H.J., You S.K. et al. Meigs’ syndrome with elevated serum CA-125 level in a case of ovarian fibrothecoma. Eur J Gynaecol Oncol. 2014;35(6):734–7.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chen H., Liu Y., Shen L.F. et al. Ovarian thecoma-fibroma groups: clinical and sonographic features with pathological comparison. J Ovarian Res. 2016;22;9(1):81. DOI: 10.1186/s13048-016-0291-2.</mixed-citation><mixed-citation xml:lang="en">Chen H., Liu Y., Shen L.F. et al. Ovarian thecoma-fibroma groups: clinical and sonographic features with pathological comparison. J Ovarian Res. 2016;22;9(1):81. DOI: 10.1186/s13048-016-0291-2.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kang M., Lee K.B., Park Y.H., Cho H.Y. First reported case of intrahepatic cholangiocarcinoma metastasis to thecoma. J Obstet Gynaecol. 2019;39(3):429–431. DOI: 10.1080/01443615.2018.1504901.</mixed-citation><mixed-citation xml:lang="en">Kang M., Lee K.B., Park Y.H., Cho H.Y. First reported case of intrahepatic cholangiocarcinoma metastasis to thecoma. J Obstet Gynaecol. 2019;39(3):429–431. DOI: 10.1080/01443615.2018.1504901.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Muronda M., Russell P. Combined ovarian serous cystadenoma and thecoma. Pathology. 2018;50(3):367–9. DOI: 10.1016/j.pathol.2017.09.026.</mixed-citation><mixed-citation xml:lang="en">Muronda M., Russell P. Combined ovarian serous cystadenoma and thecoma. Pathology. 2018;50(3):367–9. DOI: 10.1016/j.pathol.2017.09.026.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Di Lorito A., Viola P., Rosini S., Lattanzio G. Cellular fibroma in the Douglas cavity, mimicking a malignant neoplasia: fibroma, fibrosarcomaor mitotically active cellular fibroma? Pathologica. 2016;108(1):34–7.</mixed-citation><mixed-citation xml:lang="en">Di Lorito A., Viola P., Rosini S., Lattanzio G. Cellular fibroma in the Douglas cavity, mimicking a malignant neoplasia: fibroma, fibrosarcomaor mitotically active cellular fibroma? Pathologica. 2016;108(1):34–7.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ozdemir O., Sari M.E., Sen E. et al. Primary ovarian fibrosarcoma: a case report and review of the literature. J Exp Ther Oncol. 2016;11(3):225–35.</mixed-citation><mixed-citation xml:lang="en">Ozdemir O., Sari M.E., Sen E. et al. Primary ovarian fibrosarcoma: a case report and review of the literature. J Exp Ther Oncol. 2016;11(3):225–35.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Alvarado-Cabrero I., Valencia-Cedillo R., Mohs-Alfaro M., De Anda- González J. Ovarian dysgerminoma associated with fibrosarcoma: a case report. Int J Gynecol Pathol. 2011;30(5):466–9. DOI: 10.1097/PGP.0b013e318217139e.</mixed-citation><mixed-citation xml:lang="en">Alvarado-Cabrero I., Valencia-Cedillo R., Mohs-Alfaro M., De Anda- González J. Ovarian dysgerminoma associated with fibrosarcoma: a case report. Int J Gynecol Pathol. 2011;30(5):466–9. DOI: 10.1097/PGP.0b013e318217139e.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Zong L., Lin M., Fan X. Mitotically active cellular fibroma of ovary should be differentiated from fibrosarcoma: a case report and review of literature. Int J Clin Exp Pathol. 2014;7(11):7578–82.</mixed-citation><mixed-citation xml:lang="en">Zong L., Lin M., Fan X. Mitotically active cellular fibroma of ovary should be differentiated from fibrosarcoma: a case report and review of literature. Int J Clin Exp Pathol. 2014;7(11):7578–82.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J., Papanastasopoulos P., Savage P. et al. A unique case of extraovarian sex-cord stromal fibrosarcoma, with subsequent relapse of differentiated sex-cord tumor. Int J Gynecol Pathol. 2015;34(4):363–8. DOI: 10.1097/PGP.0000000000000151.</mixed-citation><mixed-citation xml:lang="en">Wang J., Papanastasopoulos P., Savage P. et al. A unique case of extraovarian sex-cord stromal fibrosarcoma, with subsequent relapse of differentiated sex-cord tumor. Int J Gynecol Pathol. 2015;34(4):363–8. DOI: 10.1097/PGP.0000000000000151.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Miura M., Suzuki S., Shibata K. et al. Estrogen producing ovarian fibrosarcoma: A case report. Nagoya J Med Sci. 2019;81(1):171–6. DOI: 10.18999/nagjms.81.1.171.</mixed-citation><mixed-citation xml:lang="en">Miura M., Suzuki S., Shibata K. et al. Estrogen producing ovarian fibrosarcoma: A case report. Nagoya J Med Sci. 2019;81(1):171–6. DOI: 10.18999/nagjms.81.1.171.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Mizumoto T., Toyama H., Asari S. et al. A case of recurrent ovarian fibrosarcoma resected by pancreaticoduodenectomy. Gan To Kagaku Ryoho. 2016;43(12):2193–5. (In Japanese).</mixed-citation><mixed-citation xml:lang="en">Mizumoto T., Toyama H., Asari S. et al. A case of recurrent ovarian fibrosarcoma resected by pancreaticoduodenectomy. Gan To Kagaku Ryoho. 2016;43(12):2193–5. (In Japanese).</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Yazdani S., Alijanpoor A., Sharbatdaran M. et al. Meigs’ syndrome with elevated serum CA-125 in a case of ovarian fibroma/thecoma. Caspian J Intern Med. 2014;5(1):43–5.</mixed-citation><mixed-citation xml:lang="en">Yazdani S., Alijanpoor A., Sharbatdaran M. et al. Meigs’ syndrome with elevated serum CA-125 in a case of ovarian fibroma/thecoma. Caspian J Intern Med. 2014;5(1):43–5.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
